| Clinical data | |
|---|---|
| Trade names | Akton, Cloxam, Clozal, Elum, Olcadil, and Sepazon[1] |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Eliminationhalf-life | 65 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H14Cl2N2O2 |
| Molar mass | 349.21 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Cloxazolam is abenzodiazepine derivative that hasanxiolytic,sedative, andanticonvulsant properties.[3][4] It is not widely used;[3] as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan.[1] In 2019, it has been retired from the Belgian market.[5]